In addition, the analysis of molecular database of GC show that CELF2 but not ESRP1 is associated with shorter overall survival (Supplemental Fig.S8D), maybe at least in part thanks to its role on CD44 alternative splicing and CD44v3 expression. The gene discussed is ESRP1; the disease is gastric cancer.